TEPANIL TEN-TAB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tepanil Ten-tab, and when can generic versions of Tepanil Ten-tab launch?
Tepanil Ten-tab is a drug marketed by 3M and is included in one NDA.
The generic ingredient in TEPANIL TEN-TAB is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tepanil Ten-tab
A generic version of TEPANIL TEN-TAB was approved as diethylpropion hydrochloride by AVANTHI INC on December 22nd, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TEPANIL TEN-TAB?
- What are the global sales for TEPANIL TEN-TAB?
- What is Average Wholesale Price for TEPANIL TEN-TAB?
Summary for TEPANIL TEN-TAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Patent Applications: | 787 |
| DailyMed Link: | TEPANIL TEN-TAB at DailyMed |
US Patents and Regulatory Information for TEPANIL TEN-TAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | TEPANIL TEN-TAB | diethylpropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 017956-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
